Can Pepoderma formulate the finished product?

Pepoderma can support formulation-fit questions and private-label/OEM paths, but the right scope depends on the buyer's formula, brand, and destination-market needs.

Should formulation questions be asked before price negotiation?

Often yes. A technically unsuitable active or carrier choice can make a low price irrelevant, so compatibility should be checked early.

Formulation support

Peptide formulation support for skincare launch teams

Peptide actives are not plug-and-play. pH, carrier system, chelators, reductants, preservative strategy, and product story all affect whether a sample becomes a stable launch formula.

Start with a sample

Buyer proof

Use-level guidance by active

Buyer proof

Carrier and pH compatibility review

Buyer proof

Stability-risk questions before bulk

Buyer proof

Formulator-friendly documentation language

Common formulation friction

Most peptide-active problems appear after a buyer has already committed to a base. Pepoderma pushes compatibility review earlier so the first sample trial is more useful.

Copper peptides with chelators or strong reducers
Lipidated peptides in high-water systems
High active load with poor sensory outcome
Preservative and pH mismatch

What to send Pepoderma

The fastest useful answer comes when the buyer shares the active, formula type, target market, desired claim direction, and any known pH or carrier constraints.

Active or INCI name
Serum, cream, ampoule, scalp tonic, or cleanser format
Target use level and launch timing
Documents needed by the buyer's compliance team